Jnj-54,728,518
Jnj-54,728,518 has been studied in 1 paper since 2021: none in people yet, 1 review. No study of it in people or animals has been published yet. The newest paper, Jul 6, 2021: “Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity”.
1 paper studies itUpdated
Latest
Expert Opinion on Emerging Drugs
Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity
ReviewGLP-1 receptor agonists